Ressources

We examined acceptability of and preferences for potential medications for treating methamphetamine use disorder (MUD) among people who use methamphetamine and examined how benefits and drawbacks o

A scoping review was undertaken to examine the impact of methamphetamine use on medications for opioid use disorder [MOUD] retention.

We conducted a qualitative study evaluating one opioid treatment program's experience, including benefits and challenges with implementing a methadone van, to inform future policy and clinical prac

We discuss major domains of xylazine’s harm, current knowledge deficits, clinical and harm reduction strategies for minimizing harm, and xylazine’s public health and policy context.

The COVID-19 pandemic led to an unprecedented relaxation of restrictions on take-home doses in opioid agonist treatment (OAT).

Emerging literature suggests that healthcare workers also experience moral injury, particularly in the context of the ongoing COVID-19 pandemic.

In this study, we seek to evaluate the experiences of Black individuals with OUD in seeking treatment.

Using the Province of British Columbia, Canada, as a case study, we undertook an evidence-based multi-criteria policy analysis of three models for defining personal possession: 1) a model that defi

Notre objectif consistait à rendre compte des expériences, des problèmes et des recommandations des personnes consommant de la méthamphétamine et ayant eu recours à des services hospitaliers.

Our aim was to identify the experiences, issues and recommendations of people who use methamphetamine and have accessed hospital services.

The objective of this study was to develop a neural network model to identify fentanyl and related analogues more accurately in drug samples compared to traditional analysis by technicians.